Michael A Lawless Net Worth

The estimated Net Worth of Michael A Lawless is at least $15.8 Mille dollars as of 23 August 2023. Michael Lawless owns over 15,051 units of Rewalk Robotics Ltd stock worth over $15,804 and over the last 2 years Michael sold RWLK stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Lawless RWLK stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Rewalk Robotics Ltd stock since 2023, according to the Form 4 filled with the SEC. Most recently Michael bought 15,051 units of RWLK stock worth $9,332 on 23 August 2023.

The largest trade Michael's ever made was buying 15,051 units of Rewalk Robotics Ltd stock on 23 August 2023 worth over $9,332. On average, Michael trades about 5,017 units every 0 days since 2022. As of 23 August 2023 Michael still owns at least 15,051 units of Rewalk Robotics Ltd stock.

You can see the complete history of Michael Lawless stock trades at the bottom of the page.

What's Michael Lawless's mailing address?

Michael's mailing address filed with the SEC is C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT, L3, 20692203.

Insiders trading at Rewalk Robotics Ltd

Over the last 9 years, insiders at Rewalk Robotics Ltd have traded over $7,660,045 worth of Rewalk Robotics Ltd stock and bought 8,170,475 units worth $6,701,652 . The most active insiders traders include Global Fund Ii Lp Lind Glob..., Glenn P Muir e Wayne Weisman. On average, Rewalk Robotics Ltd executives and independent directors trade stock every 26 days with the average trade being worth of $88,081. The most recent stock trade was executed by Global Fund Ii Lp Lind on 17 November 2023, trading 54,917 units of RWLK stock currently worth $40,089.

What does Rewalk Robotics Ltd do?

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the

Complete history of Michael Lawless stock trades at Rewalk Robotics Ltd

Rewalk Robotics Ltd executives and stock owners

Rewalk Robotics Ltd executives and other stock owners filed with the SEC include:

• Lawrence Jasinski,
  Chief Executive Officer, Director
• Lawrence J. Jasinski,
  CEO & Director
• Ori Gon,
  CFO & Principal Accounting Officer
• Wayne Weisman,
  Independent Director
• John Poduska,
  Independent Director
• Randel Richner,
  Director
• Yasushi Ichiki,
  Director
• Yohanan Engelhardt,
  Director
• Aryeh Dan,
  Director
• Jeff Dykan,
  Independent Chairman of the Board
• Jodi Gricci,
  Vice President - Global Marketing and Training
• Ofir Koren,
  Vice President - Research & Development
• Ori Gon,
  Chief Financial Officer
• Kathleen O'Donnell,
  VP of Marketing & New Bus. Devel.
• Ami Kraft,
  Exec. Advisor to the CEO
• Judy Kula,
  VP of Customer Service, HR & Bus. Affairs
• Andy Dolan,
  VP of Marketing & Reimbursement
• Miri Pariente,
  VP of Operations, Regulatory & Quality
• Peter Wehrly,
  Director
• Kevin Hershberger,
  Chief Financial Officer
• Vitalife Partners (Israel) ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Glenn P Muir,
  Director
• Deborah Di Sanzo Eldracher,
  Director
• Vitalife Partners (Israel) ...,
  
• John Vincent Hamilton,
  VP, Regulatory & Clinical
• Chunlin Han,
  Director
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners (Israel) ...,
  
• Ning Cong,
  
• Global Fund Ii Lp Lind Glob...,
  
• Joseph E Jr Turk,
  Director
• Jeannine Lynch,
  VP of Market Access & Strategy
• Hadar Levy,
  Director
• Almog Adar,
  VP of Finance
• Michael A Lawless,
  Chief Financial Officer
• Global Fund Ii Lp Lind,
  
• Charles Remsberg,
  Chief Sales Officer